Sona Nanotech Inc.

Recent News

  • Sona Nanotech Announces Validation Results for its COVID-19 Antigen Test

    Halifax, Nova Scotia--(Newsfile Corp. - July 2, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company"), a developer of rapid, point-of-care diagnostic tests, is pleased to announce that its rapid detection, COVID-19 antigen test's laboratory validation studies of performance levels have resulted in a test sensitivity of 96%,...

    2020-07-02 2:52 PM ET
  • Sona Nanotech Comments on Trading Activity at Request of IIROC

    Halifax, Nova Scotia--(Newsfile Corp. - June 1, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company") has been requested by the Investment Industry Regulatory Organization of Canada (IIROC) to comment on the recent increase in the trading volume and price of the Company's common shares. The Company is...

    2020-06-01 9:50 AM ET
  • Sona Nanotech Engages MRIGlobal for COVID-19 Test Validation Studies

    Halifax, Nova Scotia--(Newsfile Corp. - May 22, 2020) -  Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company") is pleased to announce the engagement of MRIGlobal, a leading applied scientific research organization, to provide analytical and clinical validation studies for Sona's COVID-19 rapid detection, point-of-care, antigen test which will be...

    2020-05-22 7:00 AM ET
  • Sona Nanotech Provides COVID-19 Antigen Test Progress Update

    Halifax, Nova Scotia--(Newsfile Corp. - May 12, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company") is pleased to provide the following update on the development of its rapid-response, COVID-19 antigen test. The Company received confirmation from an independent laboratory that its test achieved a positive...

    2020-05-12 7:28 AM ET
  • Sona Nanotech Provides a Progress Update on its Covid-19 Antigen Test

    Halifax, Nova Scotia--(Newsfile Corp. - April 13, 2020) -  Sona Nanotech Inc. (CSE: SONA) (OTC PINK: SNANF) (the "Company") is pleased to provide an update on the development, manufacturing arrangements and pre-orders for its Covid-19 antigen test. The Company this past week has: Progressed from feasibility and prototype testing...

    2020-04-13 7:05 AM ET
  • Sona Nanotech Awarded $4.1 Million from NGen for Rapid Development and Launch of COVID-19 Antigen Test

    Halifax, Nova Scotia--(Newsfile Corp. - March 31, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC Pink: SNANF) (the "Company") is pleased to announce that it has been awarded a $4.1 million grant from NGen, Canada's Advanced Manufacturing Supercluster, to develop and commercialize its Covid-19 rapid-response antigen test. This non-repayable...

    2020-03-31 4:32 PM ET
  • Sona Nanotech Enters into a Manufacturing Service Agreement and a Sale Letter of Intent Agreement for 2mm Tests

    Halifax, Nova Scotia--(Newsfile Corp. - March 30, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTC Pink: SNANF) (the "Company") entered into service and supply agreements with a contract manufacturing organization (CMO) in Europe for the manufacture of its Covid-19 virus-detecting, rapid-response test. The Company also entered into a letter...

    2020-03-30 1:00 PM ET
  • Sona Nanotech Obtains New OTC Trading Symbol

    Halifax, Nova Scotia--(Newsfile Corp. - March 20, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC Pink: SNANF) (the "Company") is pleased to announce that it has undertaken to further develop the U.S. trading market for its common shares. As a first step, Sona recently applied for a new OTC trading...

    2020-03-20 8:10 AM ET